Justice Ginsburg Underwent 3-Week Radiation Treatment For Pancreatic Cancer

Associate Justice Ruth Bader Ginsburg poses for the official photo at the Supreme Court in Washington, DC on November 30, 2018. (Photo by MANDEL NGAN / AFP) (Photo credit should read MANDEL NGAN/AFP/Getty Images)
Start your day with TPM.
Sign up for the Morning Memo newsletter

Supreme Court Justice Ruth Bader Ginsburg received radiation treatment for pancreatic cancer this month, the court said in a press release.

The treatments began on August 5 and were completed Friday. The tumor was first detected in July.

“The tumor was treated definitively and there is no evidence of disease elsewhere in the body,” the statement said, adding that, while the 86-year-old justice will continue undergo tests and scans, no further treatment is needed at this time.

“The Justice tolerated treatment well. She cancelled her annual summer visit to Santa Fe, but has otherwise maintained an active schedule,” the statement said.

Read full the statement below:

Justice Ruth Bader Ginsburg today completed a three-week course of stereotactic ablative radiation therapy at Memorial Sloan Kettering Cancer Center in New York City. The focused radiation treatment began on August 5 and was administered on an outpatient basis to treat a tumor on her pancreas. The abnormality was first detected after a routine blood test in early July, and a biopsy performed on July 31 at Sloan Kettering confirmed a localized malignant tumor. As part of her treatment, a bile duct stent was placed. The Justice tolerated treatment well. She cancelled her annual summer visit to Santa Fe, but has otherwise maintained an active schedule. The tumor was treated definitively and there is no evidence of disease elsewhere in the body. Justice Ginsburg will continue to have periodic blood tests and scans. No further treatment is needed at this time.

Latest DC
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: